PV Bulletin

Proposed Changes to Medical Device Information Sharing in Australia

The TGA seeks feedback on improving reporting requirements for medical device safety data.

PV Impact Brief

Urgency: HighConfidence: high

What changed

The TGA has proposed new requirements for public reporting of post-market safety data, which includes a mandate for sponsors to share performance data and results of safety investigations.

Why it matters

These changes aim to increase transparency and public access to safety information regarding medical devices, thereby improving patient safety and trust in medical device regulation.

Action needed

Regulatory teams must prepare for and implement processes for increased public disclosures and reporting obligations regarding medical device safety data in Australia.

Relevant for
Regulatory Intelligence LeadSignal Management LeadQPPV
Processes impacted
Signal ManagementCountry Compliance
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Policy change details

Document type
Consultation
Policy status
Consultation
Publication date
2026-08-13
Policy change
The TGA is seeking feedback on proposals to improve information sharing about the safety, quality, and performance of medical devices following post-market reviews or investigations. The initiative aims to provide patients and the public with better access to safety data and regulatory findings.

Key changes

Proposals for increased public disclosure of safety investigation results; new requirements for sponsors to share post-market performance data; enhancements to the TGA's public-facing safety information portals for medical devices.

Affected workflows

Signal ManagementCountry Compliance

Responsible groups

Medical Device VigilanceRegulatory AffairsPublic Relations

PV impact

This consultation proposes increased transparency and public reporting requirements for post-market safety data in Australia. It reflects a shift towards more proactive safety communication, requiring sponsors to prepare for greater public disclosure of vigilance findings and investigation outcomes.

View regulator source

Evidence and confidence

Confidence: highSource updated: Aug 13, 2026

Full briefing

Practical implication

Regulatory teams must prepare for and implement processes for increased public disclosures and reporting obligations regarding medical device safety data in Australia.

The Therapeutic Goods Administration (TGA) is consulting on proposals to enhance how safety, quality, and performance data for medical devices is shared. Key proposals include increased public disclosure of investigation results and new mandates for sponsors to provide post-market performance data. This marks a shift towards more proactive communication on safety findings.

What changed: The TGA has proposed new requirements for public reporting of post-market safety data, which includes a mandate for sponsors to share performance data and results of safety investigations.

Why it matters: These changes aim to increase transparency and public access to safety information regarding medical devices, thereby improving patient safety and trust in medical device regulation.

Practical implication: Regulatory teams must prepare for and implement processes for increased public disclosures and reporting obligations regarding medical device safety data in Australia.

View original source

Published from the Firecrawl policy change extraction pipeline.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward